Galectin-1 inhibitor (Galecto Biotech AB)

N/A

Report date: 2025/03/20 15:49:32
NME

Base Information

Drug NameGalectin-1 inhibitor (Galecto Biotech AB)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGalectin-1 inhibitors
TargetsGalectin-1
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGalecto Biotech AB
China Registration ClassN/A

Develop Information

Active CompaniesGalecto Biotech AB
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A